After lagundi, a new batch of plant-based drugs

MANILA, Philippines — The Department of Science and Technology (DOST) will soon come out with a banner crop of 18 plant-based chemicals that can be developed into herbal supplements to address common ailments.

Dean Rowena Guevara, DOST undersecretary for research and development, said R&D on the “chemicals” has been completed, making them ready for commercialization.

Guevara told The STAR that supplement and drug companies can now invest in these 18 chemicals.

Interested adopters for commercialization have to negotiate licenses with the DOST, which has readied a system for technology transfer and licensing complete with a fairness opinion evaluation system.

The ailments addressed by the 18 chemicals are pain, gout, hypertension and diabetes, which Guevara said are common diseases among Filipinos.

She said that while the chemicals are ready for development into supplements, they need to go through three stages of clinical trial before being marketed as medicines.

Science Secretary Fortunato dela Peña said the  development of the 18 plant-based chemicals into drugs showed that R&D has tremendous return on investment (ROI) potential for DOST.

“Aside from developing a pool of researchers and scientists pursuing innovative R&D, we also generate a return on investments,” Dela Peña said.

The DOST has been pouring steady investments into drug discovery and development activities mostly in academe through the Philippine Council for Health Research and Development (PCHRD), which has been implementing the Drug Discovery and Tuklas Lunas programs. 

The lagundi cough medicine had been developed by researchers and scientists in the University of the Philippines Manila with R&D grants from DOST.

Dela Peña said the department had allocated P200 million for its grants-in-aid funding which can be tapped for drug discovery and R&D, and PCHRD was allocated P130 million, bringing to P330 million the DOST’s total budget for drug discovery and development activities. 

Source: https://www.philstar.com/business/science-and-environment/2019/09/05/1949222/after-lagundi-new-batch-plant-based-drugs

Other News from

PH, Taiwan accepting applications for science graduate courses for 2020
Posted: Tuesday, January 07, 2020
The deadline for submissions of MECO-TECO SSP applications is on January 15, 2020 This is a press release from the Department of Science and Technology-Science Education Institute (DOST-SEI). ...   read full story

MOA expo puts garment, leather textile industries in the spotlight
Posted: Thursday, November 21, 2019
The Philippines’s garment, leather, and textile industries will take center stage at the “Philippine Garment, Leather Goods and Fabric Expo” set from December 5 to 8, 2019, at the SMX Convention Cente...   read full story

Bagyong Ramon, tutumbukin ang Babuyan Islands
Posted: Wednesday, November 20, 2019
Patuloy na lumalapit ng Babuyan Islands ang Typhoon Ramon. Huling namataan ang bagyo sa layong 120 kilometers silangan ng Aparri, Cagayan. Napanatili nito ang lakas ng hanging nasa 120 kilometers ...   read full story

PHL technologies presented in Asia Pacific symposium in Korea
Posted: Tuesday, November 19, 2019
RDA-FFTC Joint International Symposium guest speakers from seven Asian countries (Japan, Korea, Malaysia, Philippines, Taiwan, Thailand, Vietnam) with RDA officials (Image credit: Kai-Min Hsiung, F...   read full story